Latest Breaking News On - Padua university hospital - Page 1 : comparemela.com

Resuming DOAC After Anticoagulation-Related Events Decreases Subsequent Event Risk

Resuming oral anticoagulation therapy after an anticoagulation-related event is associated with decreased risk for future events.

Padua university hospitalInternational journal of cardiologyInternational journal

Myocarditis and Immunosuppression in Inflammatory Bowel Disease

Some patients with inflammatory bowel disease and myocarditis may benefit from immunosuppression therapy.

Gastroenterology clinic of padua university hospitalInternational journal of cardiologyColitis organization criteriaGroup of myocardialInternational journalGastroenterology clinicPadua university hospital

Lipedema: A Not-Uncommon Disease Still Goes Unrecognized

Approximately 10% of the global female population develop lipedema, a condition of unknown origin that can often be mistaken for obesity.

Comunidad autonoma de catalunaWorld health organization international classification of diseasesNational health systemLausanne university hospitalPadua university hospitalNutrition centerSpanish association of women with lipedemaWorld health organizationInternational classificationSpanish associationWomen with lipedemaPain managementPain managementPhysical activityQuality of lifeEalth related quality of life

Oral Immunotherapy: Psych Support Improves Treatment Success

Young patients undergoing food oral immunotherapy and their families may need psychological support to help them complete the challenging treatment, researchers in Italy report.

United statesChristinae ciaccioAntonella muraroLaura polloniUniversity of chicago medicineFood allergy referral centrePadua university hospitalMedscape medicalNorthern italyMedscape medical newsChicago medicineBig impactFood allergyAnaphylactic shockAnxiety disorderBiologic therapy

Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access

Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United statesSesto san giovanniUnited kingdomMaggie lai comradisDepartment of neurologyBlood disorders centerEuropean commissionGene therapy programRegulatory agency libmeldyDivision of pediatric hematologyPadua university hospitalPadua universityDepartment of specialistic neurological rehabilitationOspedale san raffaeleRegulatory agencyMaggie lai